TY - JOUR T1 - Rapid SARS-CoV-2 antigen detection by immunofluorescence – a new tool to detect infectivity JF - medRxiv DO - 10.1101/2020.10.04.20206466 SP - 2020.10.04.20206466 AU - Lorena Porte AU - Paulette Legarraga AU - Mirentxu Iruretagoyena AU - Valeska Vollrath AU - Gabriel Pizarro AU - José M. Munita AU - Rafael Araos AU - Thomas Weitzel Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/10/06/2020.10.04.20206466.abstract N2 - The evaluated SARS-CoV-2 antigen rapid fluorescence immunoassays reliably identified patients within the first 5 days of symptom onset, when respiratory secretions carried high viral loads. This high performance suggests that these tests might play an important role for future PCR-independent strategies to detect early or infective cases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThere is no conflict of interest. No external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the institutional review board (Comité Ético Científico, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile) and a waiver of informed consent was granted.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData referred to in the manuscript will be available once it is published in a peer-reviewed journal. ER -